Carlos A Zarate

Publication Activity (10 Years)

Years Active: 2021-2024
Publications (10 Years): 14

Top Topics

Pain Management

Major Depressive Disorder

Prefrontal Cortex

Preterm Infants

Top Venues

Journal of clinical psychopharmacology

Social cognitive and affective neuroscience

Psychological medicine

Revista brasileira de psiquiatria (Sao Paulo, Brazil : 1999)

This page only lists publications with an associated author ORCID identifier.

Publications

Yoojin Lee, Jessica R Gilbert, Laura R Waldman, Carlos A Zarate, Elizabeth D Ballard
Potential association between suicide risk, aggression, impulsivity, and the somatosensory system. Social cognitive and affective neuroscience 19 (1) (2024)
Yoojin Lee, Jessica R Gilbert, Laura R Waldman, Carlos A Zarate, Elizabeth D Ballard
Potential association between suicide risk, aggression, impulsivity, and the somatosensory system. Social cognitive and affective neuroscience 19 (1) (2024)
Jenessa N Johnston, Carlos A Zarate, Mark D Kvarta
Esketamine in depression: putative biomarkers from clinical research. European archives of psychiatry and clinical neuroscience (2024)
Yoojin Lee, Jessica R Gilbert, Laura R Waldman, Carlos A Zarate, Elizabeth D Ballard
Potential association between suicide risk, aggression, impulsivity, and the somatosensory system. Social cognitive and affective neuroscience 19 (1) (2024)
Brandi Quintanilla, Gustavo C Medeiros, Dede Greenstein, Peixiong Yuan, Jenessa N Johnston, Lawrence T Park, Fernando S Goes, Todd D Gould, Carlos A Zarate
κ-Opioid Receptor Plasma Levels Are Associated With Sex and Diagnosis of Major Depressive Disorder But Not Response to Ketamine. Journal of clinical psychopharmacology 43 (2) (2023)
Brandi Quintanilla, Gustavo C Medeiros, Dede Greenstein, Peixiong Yuan, Jenessa N Johnston, Lawrence T Park, Fernando S Goes, Todd D Gould, Carlos A Zarate
κ-Opioid Receptor Plasma Levels Are Associated With Sex and Diagnosis of Major Depressive Disorder But Not Response to Ketamine. Journal of clinical psychopharmacology (2023)
Brandi Quintanilla, Gustavo C Medeiros, Dede Greenstein, Peixiong Yuan, Jenessa N Johnston, Lawrence T Park, Fernando S Goes, Todd D Gould, Carlos A Zarate
κ-Opioid Receptor Plasma Levels Are Associated With Sex and Diagnosis of Major Depressive Disorder But Not Response to Ketamine. Journal of clinical psychopharmacology 43 (2) (2023)
Steven J Lamontagne, Jessica R Gilbert, Paloma K Zabala, Laura R Waldman, Carlos A Zarate, Elizabeth D Ballard
Clinical, behavioral, and electrophysiological profiles along a continuum of suicide risk: evidence from an implicit association task. Psychological medicine (2023)
Brandi Quintanilla, Gustavo C Medeiros, Dede Greenstein, Peixiong Yuan, Jenessa N Johnston, Lawrence T Park, Fernando S Goes, Todd D Gould, Carlos A Zarate
κ-Opioid Receptor Plasma Levels Are Associated With Sex and Diagnosis of Major Depressive Disorder But Not Response to Ketamine. Journal of clinical psychopharmacology 43 (2) (2023)
Brandi Quintanilla, Gustavo C Medeiros, Dede Greenstein, Peixiong Yuan, Jenessa N Johnston, Lawrence T Park, Fernando S Goes, Todd D Gould, Carlos A Zarate
κ-Opioid Receptor Plasma Levels Are Associated With Sex and Diagnosis of Major Depressive Disorder But Not Response to Ketamine. Journal of clinical psychopharmacology 43 (2) (2023)
Mani Yavi, Holim Lee, Ioline D Henter, Lawrence T Park, Carlos A Zarate
Ketamine treatment for depression: a review. Discover mental health 2 (1) (2022)
Carlos A Zarate
Commentary on the Canadian Network for Mood and Anxiety Treatments (CANMAT) Task Force Recommendations for the Use of Racemic Ketamine in Adults with Major Depressive Disorder. Canadian journal of psychiatry. Revue canadienne de psychiatrie 66 (6) (2021)
Carlos A Zarate
Ketamine: a new chapter in antidepressant development. Revista brasileira de psiquiatria (Sao Paulo, Brazil : 1999) 42 (6) (2021)
Ioline D Henter, Lawrence T Park, Carlos A Zarate
Novel Glutamatergic Modulators for the Treatment of Mood Disorders: Current Status. CNS drugs 35 (5) (2021)